Quantcast

Latest clozapine Stories

2010-01-11 00:27:00

EAST HANOVER, N.J., Jan. 11 /PRNewswire/ -- Novartis announced that Fanapt(TM) (iloperidone) tablets are now available for use across the US for the acute treatment of schizophrenia in adults. Fanapt is a twice-daily, oral antipsychotic, approved by the US Food and Drug Administration (FDA) in May 2009. To view the multimedia assets associated with this release, please click: http://multivu.prnewswire.com/mnr/novartis/41871/ "Schizophrenia remains one of the most debilitating and...

cfa4757f88872308eb916a85509023fc1
2009-07-13 13:10:00

A Finnish research study suggests that thousands of people with schizophrenia worldwide could have been saved if doctors had prescribed them the anti-psychotic drug clozapine, The Associated Press reported. Clozapine, which was introduced in the 1970s, was banned for a decade when studies showed that up to 2 percent of patients experienced agranulocytosis, a potentially fatal decline in white blood cells, while taking the drug. It was the first of a new generation of schizophrenia drugs,...

2009-01-14 17:03:00

ROCKVILLE, Md., Jan 14 /PRNewswire-USNewswire/ -- Patients ages 30 to 74 who took atypical antipsychotics such as risperidone (sold as Risperdal), quetiapine (Seroquel), olanzapine (Zyprexa) and clozapine (Clozaril) had a significantly higher risk of sudden death from cardiac arrhythmias and other cardiac causes than patients who did not take these medications, according to a new study funded by HHS' Agency for Healthcare Research and Quality. The risk of death increased with higher doses of...

2008-10-03 12:00:27

Orexigen Therapeutics, a biopharmaceutical company focused on the treatment of obesity and other central nervous system-related disorders, has initiated its first Phase IIa clinical trial with OREX-003, a proprietary sustained release formulation of zonisamide plus olanzapine. The Phase IIa clinical trial, OZ-101, is designed to examine the effectiveness of OREX-003 in mitigating drug-associated weight gain or other metabolic consequences commonly experienced by patients taking atypical...

2008-09-04 12:00:32

US-based pharmaceutical company Corcept Therapeutics has announced that Eli Lilly and Company has agreed to fund studies to test the effectiveness of Corcept's selective GRII receptor antagonist, CORT 108297, in rat models of olanzapine induced weight gain. Corcept has previously published the results of studies in rats that demonstrated that CORLUX, a potent GRII (cortisol) receptor antagonist, both reduced the weight gain associated with the ongoing use of olanzapine and mitigated the...

2006-07-06 15:43:30

By Anthony J. Brown, MD NEW YORK (Reuters Health) - The drug clozapine is more effective than olanzapine or haloperidol at reducing aggressive behavior in violent patients with schizophrenia, new research shows. This ability to curb aggressiveness seems to be separate from the drug's antipsychotic effect. Schizophrenia is a severe psychiatric disorder in which patients experience distorted thinking, hallucinations and abnormal emotions. The disease is classified as a psychotic...

2006-07-05 18:31:35

NEW YORK (Reuters Health) - Treatment with clozapine, considered one of the most effective antipsychotic drugs, appears to increase the risk of developing metabolic syndrome, according to a report in the American Journal of Psychiatry. Metabolic syndrome is a cluster of conditions that includes obesity, high triglyceride levels, high blood pressure and high blood sugar levels. People with the syndrome are at increased risk for heart attacks and stroke. "Clozapine is the last hope for...

2006-06-06 08:53:07

By Karla Gale NEW YORK (Reuters Health) - The prescription of antipsychotic medications for children and adolescents in the US increased nearly 6-fold between 1993 and 2002, according to survey results. The US Food and Drug Administration has approved only three antipsychotic drugs - haloperidol, thioridazine hydrochloride and pimozide -- for use in patients younger than 18 years, but most of the prescriptions written were for newer medications. "What was most striking is that...

2006-02-01 17:00:00

By Gene Emery BOSTON (Reuters) - Schizophrenics who took two antipsychotic drugs showed no more improvement than those on a single drug, raising doubts about the benefit of using multiple medicines to treat the disease, a study said on Wednesday. The study, published in the New England Journal of Medicine, tested 68 patients who responded poorly to clozapine, the generic version of Novartis AG's Clozaril. Half the group took clozapine along with Johnson & Johnson's antipsychotic...

2006-02-01 17:00:00

By Gene Emery BOSTON (Reuters) - Schizophrenics who took two antipsychotic drugs showed no more improvement than those on a single drug, raising doubts about the benefit of using multiple medicines to treat the disease, a study said on Wednesday. The study, published in the New England Journal of Medicine, tested 68 patients who responded poorly to clozapine, the generic version of Novartis AG's Clozaril. Half the group took clozapine along with Johnson & Johnson's antipsychotic...


Word of the Day
cenobite
  • One of a religious order living in a convent or in community; a monk: opposed to anchoret or hermit (one who lives in solitude).
  • A social bee.
This word comes from the Latin 'coenobium,' convent, which comes from the Greek 'koinobios,' living in community.
Related